Table 1.
Organism | Antibiotic Classes Tested | Biomarkers | Year | Reference |
---|---|---|---|---|
Staphylococcus aureus | β-lactams | MRSA: 891, 1140, 1165, 1229 and 2127 m/z MSSA: 2548 and 2647 m/z |
2000 | [51] |
Staphylococcus aureus | β-lactams | Variation between in the spectral profiles in the mass range of m/z 500–3500 Da |
2002 | [52] |
Lactococcus lactis
Bacillus coagulans Escherichia coli |
Bacteriocins (lantibiotic) | Lacticin 481: 2902, 2924,2940 m/z Nisin A: 3392 m/z Coagulin: 4650 m/z |
2003 | [53] |
Escherichia coli | β-lactams | Ampicillin: 29.000 m/z | 2007 | [54] |
Bacteroides fragilis | Carbapenems | cfiA negative: 4711, 4817, 5017, 5204, 5268 m/z cfiA positive: 4688, 4826, 5002, 5189, 5282 m/z |
2011 | [55] |
Klebsiella spp. | Carbapenems | OmpK36 porin: 38000, 19000 m/z | 2012 | [56] |
Enterococcus faecium | Glycopeptides | VanA/B: 6603 m/z | 2012 | [57,58] |
Enterobacteriaceae | Carbapenems | blaKPC: 11109 m/z | 2014 | [59] |
Campylobacter jejuni | β-lactams Tetracyclines Glycopeptides |
Spectrum processing parameters increased the resistance detection | 2016 | [60] |
Staphylococcus aureus
Staphylococcus epidermidis |
β-lactams | mecA: 2415 m/z | 2016 | [61] |
Escherichia coli | Polymyxin | Lipid A modification: 1919 m/z | 2018 | [62] |
Klebsiella pneumonia Enterobacter cloacae Escherichia coli
Serratia marcescens Citrobacter braakii, Pseudomonas aeruginosa |
Carbapenems | KPC-2: 28544 m/z | 2019 | [63] |
Bacteroides fragilis | Carbapenems | Identification of B. fragilis with the validated “cfiA library” [55] | 2019 | [64] |